Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
News Medical on MSN5d
Researchers identify key factors for successful donor lymphocyte infusion in AML patientsDana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...
The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback